Psychiatry Research
Volume 153, Issue 2 , Pages 137-143 , 31 October 2007

Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests of functional brain asymmetry

Received 5 October 2006 ,Revised 9 March 2007 ,Accepted 7 April 2007.

References 

  1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571
  2. Bruder GE, Otto MW, Stewart JW, McGrath P, Fava M, Rosenbaum JF, et al. Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response. Neuropsychopharmnacology. 1996;15:171–179
  3. Bruder GE, Stewart JW, Tenke CE, McGrath PJ, Leite P, Bhattacharya N, et al. Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biological Psychiatrty. 2001;48:416–425
  4. Bruder GE, Stewart JW, McGrath PJ, Deliyannides D, Quitkin FM. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men. Neuropsychopharmacology. 2004;29:1752–1761
  5. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biological Psychiatry. 1997;41:15–22
  6. Cook IA, Leuchter AF. Prefrontal changes and treatment response prediction in depression. Seminars in Clinical Neuropsychiatry. 2001;6:113–120
  7. Dunkin JJ, Leuchter AF, Cook IA, Kasi-Godey JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. Journal of Affective Disorder. 2000;60:13–23
  8. First, M., Spitzer, R., Gibbon, M., Williams, J., 1994. The structural clinical interview for DSM-IV Axis I Disorders — Patient Edition (SCID-I/P, Version 2.0). Biometric Research Department, New York State Psychiatric Institute, New York, N.Y.
  9. Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLoed DR, Pearlson GD, Wong SH. Cerebral blood flow in obsessive–compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Research:. Neuroimaging. 2001;108:89–100
  10. Kalayam B, Alexopoulos GS. A preliminary study of left frontal region error negativity and symptom improvement in geriatric depression. American Journal of Psychiatry. 2003;160:2054–2056
  11. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Rabkin J, et al. Phenelzine v imipramine in atypical depression: a preliminary report. Archives of General Psychiatry. 1984;41:669–677
  12. Little JT, Ketter TA, Kimbrell TA, Dunn RT, Benson BE, Willis MW, et al. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression. Biological Psychiatry. 2005;57:220–228
  13. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, et al. Cingulate function in depression: a potential predictor of treatment response. NeuroReport. 1997;8:1057–1061
  14. Oldfield RC. The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia. 1971;9:97–113
  15. Papakostas GI, Worthington III JJ, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, et al. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depression and Anxiety. 2006;23:178–181
  16. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. American Journal of Psychiatry. 2001;158:405–415
  17. Rubinow DR. Treatment strategies after SSRI failure — good news and bad news. The New Journal of Medicine. 2006;354(12):1305–1307
  18. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al. Bupropion-SR, Sertraline, or Venlafaxine-XR after failure of SSRIs for depression. The New England Journal of Medicine. 2006;354(12):1231–1242
  19. Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR. Differential brain metabolic predictors of response to paroxetine in obsessive–compulsion disorder versus major depression. American Journal of Psychiatry. 2003;160:522–532
  20. Sidtis JJ. The complex tone test: implications for the assessment of auditory laterality effects. Neuropsychologia. 1981;19:103–112
  21. Stewart JW, Quitkin FM, McGrath PJ, Bruder GE. Do tricyclic responders have different brain laterality?. Journal of Abnormal Psychology. 1999;108:707–710
  22. Taylor BP, Bruder GE, Stewart JW, McGrath PJ, Halperin J, Ehrlichman H, et al. Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients. American Journal of Psychiatry. 2006;163:73–78
  23. Wexler BE, Halwes T. Increasing the power of dichotic methods. The fused rhymed words test. Neuropsychologia. 1983;21:59–66

PII: S0165-1781(07)00122-9

doi: 10.1016/j.psychres.2007.04.011

Psychiatry Research
Volume 153, Issue 2 , Pages 137-143 , 31 October 2007

Article Tools

* Image Usage & Resolution